Compare LIVN & SII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LIVN | SII |
|---|---|---|
| Founded | 1987 | 2008 |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.4B |
| IPO Year | 2015 | 2011 |
| Metric | LIVN | SII |
|---|---|---|
| Price | $74.04 | $126.04 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 1 |
| Target Price | $72.43 | ★ $132.00 |
| AVG Volume (30 Days) | ★ 786.6K | 164.5K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.11% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.40 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.79 | $26.03 |
| Revenue Next Year | $6.63 | $11.83 |
| P/E Ratio | $184.08 | ★ $63.42 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $41.02 | $57.26 |
| 52 Week High | $74.32 | $169.63 |
| Indicator | LIVN | SII |
|---|---|---|
| Relative Strength Index (RSI) | 65.24 | 40.83 |
| Support Level | $61.63 | $114.44 |
| Resistance Level | N/A | $150.09 |
| Average True Range (ATR) | 2.66 | 6.73 |
| MACD | 0.59 | -1.25 |
| Stochastic Oscillator | 96.97 | 7.37 |
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
Sprott Inc is an alternative asset manager. The company has four reportable segments: Exchange Listed Products, which derives key revenue, and includes management services to the company's closed-end physical trusts and exchange-traded funds, both of which are actively traded on public securities exchanges; Managed equities segment provides asset management and sub-advisory services to the company's branded funds, fixed-term LPs and managed accounts; Private strategies which provide lending and streaming activities through limited partnership vehicles; and the Corporate segment which provides capital, balance sheet management and enterprise shared services to the company's subsidiaries. Geographically, it derives key revenue from Canada, followed by the United States.